First Trust NYSE Arca Biotechnology Index Fund Rating $269.22 -4.55 (-1.66%) Closing price 09/23/2026 04:10 PM EasternExtended Trading$269.27 +0.05 (+0.02%) As of 07:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsSEC FilingsShort Interest First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.64Holdings in FBT have an aggregate rating of Moderate Buy based on 474 analyst ratings issued in the past year covering 25 companies (86.5% of the portfolio).FBT Aggregate Price Target$269.22High Prediction$269.22Average Prediction$269.22Low Prediction$269.22Holdings in FBT have an aggregate price target of $269.22 and a range of $269.22 to $269.22 covering 25 companies (86.5% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FBT Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings4.46%HALOHalozyme Therapeutics$112.44-2.3%Moderate Buy$91.20 -18.9%133.1015 of 5 stars3.89%NEONeoGenomics$18.36-2.8%Moderate Buy$17.67 -3.8%101.601 of 5 stars3.89%CORTCorcept Therapeutics$112.94-3.9%Moderate Buy$138.17 22.3%83.8661 of 5 stars3.87%NTRANatera$390.790.0%Moderate Buy$330.83 -15.3%231.6001 of 5 starsTrending News3.73%REGNRegeneron Pharmaceuticals$801.82-0.3%Moderate Buy$802.18 0.0%243.7165 of 5 starsAnalyst Forecast3.68%ONCBeOne Medicines$365.00-0.8%Buy$402.71 10.3%172.7734 of 5 starsPositive NewsAnalyst UpgradeGap Up3.63%RGENRepligen$184.53-1.2%Buy$168.57 -8.6%182.3538 of 5 stars3.56%ARGXargenex$945.82-1.9%Moderate Buy$1,158.61 22.5%244.5936 of 5 stars3.55%GMABGenmab A/S$34.75-1.3%Moderate Buy$39.50 13.7%134.1118 of 5 stars3.52%BMRNBioMarin Pharmaceutical$62.21-1.8%Moderate Buy$89.17 43.3%234.3804 of 5 stars3.51%GILDGilead Sciences$151.37-0.9%Moderate Buy$158.78 4.9%293.492 of 5 starsTrending NewsAnalyst Revision3.46%BIIBBiogen$227.53+1.0%Moderate Buy$230.14 1.1%322.5385 of 5 stars3.44%ILMNIllumina$255.38+3.2%Hold$199.13 -22.0%182.2032 of 5 stars3.42%SRPTSarepta Therapeutics$18.95-8.9%Hold$24.07 27.0%193.6274 of 5 stars3.37%VRTXVertex Pharmaceuticals$516.34+0.3%Moderate Buy$573.83 11.1%233.7852 of 5 starsTrending NewsAnalyst Forecast3.35%BNTXBioNTech$98.46-2.4%Moderate Buy$126.00 28.0%193.9559 of 5 starsInsider Trade3.30%INCYIncyte$124.64-1.8%Moderate Buy$124.05 -0.5%253.1461 of 5 starsTrending NewsAnalyst Forecast3.29%AMGNAmgen$406.09-1.0%Hold$383.46 -5.6%303.6037 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.22%ADMAADMA Biologics$9.70-1.1%Moderate Buy$18.67 92.4%63.2384 of 5 stars3.21%TECHBio-Techne$72.520.0%Hold$68.92 -5.0%173.6362 of 5 stars3.16%MDGLMadrigal Pharmaceuticals$513.02-1.1%Moderate Buy$701.33 36.7%183.1076 of 5 starsAnalyst Forecast3.15%EXELExelixis$56.73-2.4%Hold$50.29 -11.4%202.4118 of 5 stars3.00%AXSMAxsome Therapeutics$193.45-4.8%Moderate Buy$271.85 40.5%223.8073 of 5 starsAnalyst Forecast2.99%TGTXTG Therapeutics$56.00-3.6%Hold$63.00 12.5%93.5368 of 5 starsAnalyst Upgrade2.88%UTHRUnited Therapeutics$489.42-1.6%Moderate Buy$621.00 26.9%144.4329 of 5 starsAnalyst ForecastInsider Trade This page (NYSEARCA:FBT) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
